Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/1999
04/07/1999EP0752884A4 Method of treating auto-immune diseases using type one interferons
04/07/1999EP0742715B1 Oral liquid compositions containing paroxetine resinate
04/07/1999EP0681474B1 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
04/07/1999CN1213372A Heterocycle-condensed morphinoid derivatives (II)
04/07/1999CN1213369A Quinoxalinediones
04/07/1999CN1213368A Hydroxamic acid based collagenase inhibitors
04/07/1999CN1213308A Method for treating mental drug abuse
04/07/1999CN1213307A Novel substituted imidazolium compounds
04/07/1999CN1213306A Novel substituted imidazolium compounds
04/07/1999CN1213304A Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives ad NMDA receptor subtype blockers
04/07/1999CN1213301A Sustained-release metal valproate tablets
04/07/1999CN1213300A Method for preventing and treating peripheral neurophathy by administering selegiline
04/07/1999CN1212966A Usage of steroi saponin for preventing and curing senile dementia and new steroid saponin
04/06/1999US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
04/06/1999US5892039 Piperazino derivatives as neurokinin antagonists
04/06/1999US5891923 Cognition activators
04/06/1999US5891899 Pharmaceutical xanthene compounds
04/06/1999US5891891 Use of imidazo 1, 2-A! pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with disfunction of the neural circuits of the basal ganglia
04/06/1999US5891887 Brain disorders
04/06/1999US5891885 Method for treating migraine
04/06/1999US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor
04/06/1999US5891876 Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (ampa); drugs that enhance these receptor currents will facilitate communication in brain networks responsible for perceptual-motor integration and higher order behaviors
04/06/1999US5891873 Particularly alzheimer's disease. examples include aminoguanidines and amphotericin b.
04/06/1999US5891871 Substituted 2,3-benzodiazepin-4-ones and the use thereof
04/06/1999US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen
04/06/1999US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA)
04/06/1999US5891670 Tetracycline resistance protein
04/06/1999US5891641 Assay for disease related conformation of a protein
04/06/1999US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies.
04/06/1999CA2003665C Pharmaceutical composition containing 1-[mono- or bis (trifluoromethyl)-2-pyridinyl] piperazines
04/06/1999CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them
04/01/1999WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes
04/01/1999WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions
04/01/1999WO1999015659A2 Human ubiquitin-conjugating enzymes
04/01/1999WO1999015657A2 53bp2 complexes
04/01/1999WO1999015635A1 Human ste20-like stress activated serine/threonine kinase
04/01/1999WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
04/01/1999WO1999015528A1 Acidic addition salts of morphine alkaloids and the application thereof
04/01/1999WO1999015526A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
04/01/1999WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999WO1999015524A1 Thiazole derivatives
04/01/1999WO1999015505A1 1,5-diphenylpyrazole derivatives
04/01/1999WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999WO1999015498A1 New npy antagonists
04/01/1999WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999WO1999015490A1 C3a receptor ligands
04/01/1999WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT
04/01/1999WO1999015191A2 Cytokines having neurotrophic activity
04/01/1999WO1999015181A1 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids
04/01/1999WO1999015177A1 Treatment of attention-deficit/hyperactivity disorder
04/01/1999WO1999015176A1 Treatment of oppositional defiant disorder
04/01/1999WO1999015171A1 Nicotine compositions and methods of formulation thereof
04/01/1999WO1999015163A1 Treatment of conduct disorder
04/01/1999WO1999015159A2 Methods for increasing apoe levels for the treatment of neurodegenerative disease
04/01/1999WO1999015016A1 Methods for regulating trka expression
04/01/1999WO1999003878A3 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
04/01/1999WO1999002497A3 Pyridine derivatives
04/01/1999WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3
04/01/1999WO1998053856A9 Methods for the detection, treatment, and prevention of neurodegeneration
04/01/1999WO1998052898A9 Pharmaceutical agents for the treatment of cerebral amyloidosis
04/01/1999WO1998048785A3 Allelic polygene diagnosis of reward deficiency syndrome and treatment
04/01/1999DE19743323A1 Solid selegiline dosage form
04/01/1999DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents
04/01/1999CA2304505A1 Methods for increasing apoe levels for the treatment of neurodegenerative disease
04/01/1999CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999CA2304115A1 Treatment of oppositional defiant disorder
04/01/1999CA2304114A1 Methods for regulating trka expression
04/01/1999CA2304112A1 Treatment of attention-deficit/hyperactivity disorder
04/01/1999CA2304042A1 Nicotine compositions and methods of formulation thereof
04/01/1999CA2303994A1 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
04/01/1999CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2303883A1 C3a receptor ligands
04/01/1999CA2303663A1 Expression of genes in hematopoietic stem cells in hischaemic conditions
04/01/1999CA2303528A1 New npy antagonists
04/01/1999CA2303405A1 53bp2 complexes
04/01/1999CA2303359A1 1,5-diphenylpyrazole derivatives
04/01/1999CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999CA2301693A1 Cytokines having neurotrophic activity
04/01/1999CA2272605A1 Pharmaceutical composition containing gp34 binding-inhibitory agent as effective ingredient
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905249A2 Alcohol dehydrogenase
03/31/1999EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it
03/31/1999EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/31/1999EP0904782A1 Remedy for spinal injury
03/31/1999EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
03/31/1999EP0904372A2 Human phospholipase inhibitor
03/31/1999EP0904349A1 Transgenic non-human mammals with progressive neurologic disease
03/31/1999EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
03/31/1999EP0904287A2 Cytokine designated lerk-8
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904283A1 Human netrin-1
03/31/1999EP0904273A1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
03/31/1999EP0904272A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904270A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
1 ... 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 ... 1833